JP Morgan Chase’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
70,000
-134,500
-66% -$20.7M ﹤0.01% 2663
2025
Q4
$31.7M Buy
204,500
+76,900
+60% +$11.5M ﹤0.01% 1681
2025
Q3
$17.8M Sell
127,600
-166,900
-57% -$22.6M ﹤0.01% 2194
2025
Q2
$39.7M Buy
294,500
+244,500
+489% +$33M ﹤0.01% 1469
2025
Q1
$7.3M Sell
50,000
-80,000
-62% -$11.6M ﹤0.01% 2826
2024
Q4
$17.9M Buy
130,000
+80,000
+160% +$11.7M ﹤0.01% 2146
2024
Q3
$7.7M Sell
50,000
-5,600
-10% -$849K ﹤0.01% 2844
2024
Q2
$8.1M Sell
55,600
-169,400
-75% -$24.3M ﹤0.01% 2642
2024
Q1
$33.2M Buy
225,000
+171,200
+318% +$24.6M ﹤0.01% 1538
2023
Q4
$7.34M Sell
53,800
-150,000
-74% -$19.5M ﹤0.01% 2761
2023
Q3
$26.2M Buy
203,800
+193,700
+1,918% +$25.7M ﹤0.01% 1485
2023
Q2
$1.34M Buy
10,100
+6,300
+166% +$830K ﹤0.01% 3830
2023
Q1
$492K Sell
3,800
-213,500
-98% -$27.9M ﹤0.01% 4517
2022
Q4
$29.5M Buy
217,300
+200,000
+1,156% +$26.5M ﹤0.01% 1393
2022
Q3
$2.1M Sell
17,300
-222,000
-93% -$28.6M ﹤0.01% 3420
2022
Q2
$30.7M Buy
239,300
+206,000
+619% +$27M ﹤0.01% 1311
2022
Q1
$4.56M Sell
33,300
-268,100
-89% -$35.5M ﹤0.01% 3081
2021
Q4
$42.5M Buy
301,400
+301,200
+150,600% +$40M ﹤0.01% 1294
2021
Q3
$25K Buy
+200
New +$26.4K ﹤0.01% 6002
2021
Q1
Sell
-99,000
Closed -$11.2M 6401
2020
Q4
$11.2M Sell
99,000
-400,000
-80% -$43.7M ﹤0.01% 2115
2020
Q3
$51.8M Buy
499,000
+400,000
+404% +$42.1M 0.01% 953
2020
Q2
$9.91M Sell
99,000
-60,000
-38% -$5.92M ﹤0.01% 1903
2020
Q1
$14.1M Buy
159,000
+27,000
+20% +$2.62M ﹤0.01% 1476
2019
Q4
$13.4M Sell
132,000
-33,800
-20% -$3.25M ﹤0.01% 1876
2019
Q3
$14.9M Hold
165,800
﹤0.01% 1818
2019
Q2
$15.3M Sell
165,800
-100
-0.1% -$8.99K ﹤0.01% 1765
2019
Q1
$15.2M Buy
165,900
+5,900
+4% +$532K ﹤0.01% 1737
2018
Q4
$13.8M Hold
160,000
﹤0.01% 1762
2018
Q3
$15.2M Hold
160,000
﹤0.01% 1872
2018
Q2
$13.4M Sell
160,000
-229,600
-59% -$19M ﹤0.01% 1913
2018
Q1
$31.7M Buy
389,600
+77,500
+25% +$6.6M 0.01% 1213
2017
Q4
$25.8M Sell
312,100
-60,000
-16% -$4.95M 0.01% 1390
2017
Q3
$30.2M Buy
372,100
+105,900
+40% +$8.5M 0.01% 1225
2017
Q2
$21.1M Sell
266,200
-111,737
-30% -$8.51M ﹤0.01% 1418
2017
Q1
$28.1M Sell
377,937
-18,663
-5% -$1.36M 0.01% 1246
2016
Q4
$27.3M Buy
+396,600
New +$27.5M 0.01% 1269
2015
Q4
Sell
-80,000
Closed -$5.3M 4820
2015
Q3
$5.3M Buy
+80,000
New +$5.85M ﹤0.01% 2185
2015
Q1
Sell
-310,600
Closed -$15.1M 4292
2014
Q4
$15.1M Buy
+310,600
New +$20.8M ﹤0.01% 1656

Other funds holding XLV

JP Morgan Chase's XLV Position: Q1 2026 in Review

JP Morgan Chase reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 5.8% in Q1 2026, selling an estimated $150M and leaving 15,794,063 shares worth $2.27B. The position accounts for 0.15% of the portfolio, ranked #145.

JP Morgan Chase first reported a position in XLV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.6B in Q4 2025. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • JP Morgan Chase held 15,794,063 shares of State Street Health Care Select Sector SPDR ETF worth $2.27B as of Q1 2026.
  • JP Morgan Chase sold 974,260 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $150M.
  • State Street Health Care Select Sector SPDR ETF made up 0.15% of JP Morgan Chase's portfolio in Q1 2026, its #145 holding.
  • JP Morgan Chase first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's State Street Health Care Select Sector SPDR ETF position peaked at $2.6B in Q4 2025.
  • 1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.